Table of Content

1 CD30 (TNFRSF8) ELISA Kit Market Overview
1.1 Product Overview and Scope of CD30 (TNFRSF8) ELISA Kit
1.2 CD30 (TNFRSF8) ELISA Kit Segment by Type
1.2.1 Global CD30 (TNFRSF8) ELISA Kit Market Value Comparison by Type (2024-2034)
1.2.2 Human
1.2.3 Mouse
1.2.4 Rat
1.2.5 Porcine
1.2.6 Others
1.3 CD30 (TNFRSF8) ELISA Kit Segment by Application
1.3.1 Global CD30 (TNFRSF8) ELISA Kit Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Research Institute
1.3.4 Others
1.4 Global CD30 (TNFRSF8) ELISA Kit Market Size Estimates and Forecasts
1.4.1 Global CD30 (TNFRSF8) ELISA Kit Revenue 2018-2029
1.4.2 Global CD30 (TNFRSF8) ELISA Kit Sales 2018-2029
1.4.3 Global CD30 (TNFRSF8) ELISA Kit Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 CD30 (TNFRSF8) ELISA Kit Market Competition by Manufacturers
2.1 Global CD30 (TNFRSF8) ELISA Kit Sales Market Share by Manufacturers (2018-2024)
2.2 Global CD30 (TNFRSF8) ELISA Kit Revenue Market Share by Manufacturers (2018-2024)
2.3 Global CD30 (TNFRSF8) ELISA Kit Average Price by Manufacturers (2018-2024)
2.4 Global CD30 (TNFRSF8) ELISA Kit Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of CD30 (TNFRSF8) ELISA Kit, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of CD30 (TNFRSF8) ELISA Kit, Product Type & Application
2.7 CD30 (TNFRSF8) ELISA Kit Market Competitive Situation and Trends
2.7.1 CD30 (TNFRSF8) ELISA Kit Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest CD30 (TNFRSF8) ELISA Kit Players Market Share by Revenue
2.7.3 Global CD30 (TNFRSF8) ELISA Kit Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 CD30 (TNFRSF8) ELISA Kit Retrospective Market Scenario by Region
3.1 Global CD30 (TNFRSF8) ELISA Kit Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global CD30 (TNFRSF8) ELISA Kit Global CD30 (TNFRSF8) ELISA Kit Sales by Region: 2018-2029
3.2.1 Global CD30 (TNFRSF8) ELISA Kit Sales by Region: 2018-2024
3.2.2 Global CD30 (TNFRSF8) ELISA Kit Sales by Region: 2024-2029
3.3 Global CD30 (TNFRSF8) ELISA Kit Global CD30 (TNFRSF8) ELISA Kit Revenue by Region: 2018-2029
3.3.1 Global CD30 (TNFRSF8) ELISA Kit Revenue by Region: 2018-2024
3.3.2 Global CD30 (TNFRSF8) ELISA Kit Revenue by Region: 2024-2029
3.4 North America CD30 (TNFRSF8) ELISA Kit Market Facts & Figures by Country
3.4.1 North America CD30 (TNFRSF8) ELISA Kit Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America CD30 (TNFRSF8) ELISA Kit Sales by Country (2018-2029)
3.4.3 North America CD30 (TNFRSF8) ELISA Kit Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe CD30 (TNFRSF8) ELISA Kit Market Facts & Figures by Country
3.5.1 Europe CD30 (TNFRSF8) ELISA Kit Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe CD30 (TNFRSF8) ELISA Kit Sales by Country (2018-2029)
3.5.3 Europe CD30 (TNFRSF8) ELISA Kit Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific CD30 (TNFRSF8) ELISA Kit Market Facts & Figures by Country
3.6.1 Asia Pacific CD30 (TNFRSF8) ELISA Kit Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific CD30 (TNFRSF8) ELISA Kit Sales by Country (2018-2029)
3.6.3 Asia Pacific CD30 (TNFRSF8) ELISA Kit Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America CD30 (TNFRSF8) ELISA Kit Market Facts & Figures by Country
3.7.1 Latin America CD30 (TNFRSF8) ELISA Kit Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America CD30 (TNFRSF8) ELISA Kit Sales by Country (2018-2029)
3.7.3 Latin America CD30 (TNFRSF8) ELISA Kit Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa CD30 (TNFRSF8) ELISA Kit Market Facts & Figures by Country
3.8.1 Middle East and Africa CD30 (TNFRSF8) ELISA Kit Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa CD30 (TNFRSF8) ELISA Kit Sales by Country (2018-2029)
3.8.3 Middle East and Africa CD30 (TNFRSF8) ELISA Kit Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global CD30 (TNFRSF8) ELISA Kit Sales by Type (2018-2029)
4.1.1 Global CD30 (TNFRSF8) ELISA Kit Sales by Type (2018-2024)
4.1.2 Global CD30 (TNFRSF8) ELISA Kit Sales by Type (2024-2029)
4.1.3 Global CD30 (TNFRSF8) ELISA Kit Sales Market Share by Type (2018-2029)
4.2 Global CD30 (TNFRSF8) ELISA Kit Revenue by Type (2018-2029)
4.2.1 Global CD30 (TNFRSF8) ELISA Kit Revenue by Type (2018-2024)
4.2.2 Global CD30 (TNFRSF8) ELISA Kit Revenue by Type (2024-2029)
4.2.3 Global CD30 (TNFRSF8) ELISA Kit Revenue Market Share by Type (2018-2029)
4.3 Global CD30 (TNFRSF8) ELISA Kit Price by Type (2018-2029)
5 Segment by Application
5.1 Global CD30 (TNFRSF8) ELISA Kit Sales by Application (2018-2029)
5.1.1 Global CD30 (TNFRSF8) ELISA Kit Sales by Application (2018-2024)
5.1.2 Global CD30 (TNFRSF8) ELISA Kit Sales by Application (2024-2029)
5.1.3 Global CD30 (TNFRSF8) ELISA Kit Sales Market Share by Application (2018-2029)
5.2 Global CD30 (TNFRSF8) ELISA Kit Revenue by Application (2018-2029)
5.2.1 Global CD30 (TNFRSF8) ELISA Kit Revenue by Application (2018-2024)
5.2.2 Global CD30 (TNFRSF8) ELISA Kit Revenue by Application (2024-2029)
5.2.3 Global CD30 (TNFRSF8) ELISA Kit Revenue Market Share by Application (2018-2029)
5.3 Global CD30 (TNFRSF8) ELISA Kit Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Sino Biological, Inc.
6.1.1 Sino Biological, Inc. Corporation Information
6.1.2 Sino Biological, Inc. Description and Business Overview
6.1.3 Sino Biological, Inc. CD30 (TNFRSF8) ELISA Kit Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Sino Biological, Inc. CD30 (TNFRSF8) ELISA Kit Product Portfolio
6.1.5 Sino Biological, Inc. Recent Developments/Updates
6.2 Bio-Techne
6.2.1 Bio-Techne Corporation Information
6.2.2 Bio-Techne Description and Business Overview
6.2.3 Bio-Techne CD30 (TNFRSF8) ELISA Kit Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Bio-Techne CD30 (TNFRSF8) ELISA Kit Product Portfolio
6.2.5 Bio-Techne Recent Developments/Updates
6.3 MyBiosource, Inc.
6.3.1 MyBiosource, Inc. Corporation Information
6.3.2 MyBiosource, Inc. Description and Business Overview
6.3.3 MyBiosource, Inc. CD30 (TNFRSF8) ELISA Kit Sales, Revenue and Gross Margin (2018-2024)
6.3.4 MyBiosource, Inc. CD30 (TNFRSF8) ELISA Kit Product Portfolio
6.3.5 MyBiosource, Inc. Recent Developments/Updates
6.4 Boster Biological Technology
6.4.1 Boster Biological Technology Corporation Information
6.4.2 Boster Biological Technology Description and Business Overview
6.4.3 Boster Biological Technology CD30 (TNFRSF8) ELISA Kit Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Boster Biological Technology CD30 (TNFRSF8) ELISA Kit Product Portfolio
6.4.5 Boster Biological Technology Recent Developments/Updates
6.5 Assay Genie
6.5.1 Assay Genie Corporation Information
6.5.2 Assay Genie Description and Business Overview
6.5.3 Assay Genie CD30 (TNFRSF8) ELISA Kit Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Assay Genie CD30 (TNFRSF8) ELISA Kit Product Portfolio
6.5.5 Assay Genie Recent Developments/Updates
6.6 Signalway Antibody LLC
6.6.1 Signalway Antibody LLC Corporation Information
6.6.2 Signalway Antibody LLC Description and Business Overview
6.6.3 Signalway Antibody LLC CD30 (TNFRSF8) ELISA Kit Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Signalway Antibody LLC CD30 (TNFRSF8) ELISA Kit Product Portfolio
6.6.5 Signalway Antibody LLC Recent Developments/Updates
6.7 Abbexa
6.6.1 Abbexa Corporation Information
6.6.2 Abbexa Description and Business Overview
6.6.3 Abbexa CD30 (TNFRSF8) ELISA Kit Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Abbexa CD30 (TNFRSF8) ELISA Kit Product Portfolio
6.7.5 Abbexa Recent Developments/Updates
6.8 RayBiotech, Inc.
6.8.1 RayBiotech, Inc. Corporation Information
6.8.2 RayBiotech, Inc. Description and Business Overview
6.8.3 RayBiotech, Inc. CD30 (TNFRSF8) ELISA Kit Sales, Revenue and Gross Margin (2018-2024)
6.8.4 RayBiotech, Inc. CD30 (TNFRSF8) ELISA Kit Product Portfolio
6.8.5 RayBiotech, Inc. Recent Developments/Updates
6.9 Thermo Fisher Scientific (China) Co., Ltd.
6.9.1 Thermo Fisher Scientific (China) Co., Ltd. Corporation Information
6.9.2 Thermo Fisher Scientific (China) Co., Ltd. Description and Business Overview
6.9.3 Thermo Fisher Scientific (China) Co., Ltd. CD30 (TNFRSF8) ELISA Kit Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Thermo Fisher Scientific (China) Co., Ltd. CD30 (TNFRSF8) ELISA Kit Product Portfolio
6.9.5 Thermo Fisher Scientific (China) Co., Ltd. Recent Developments/Updates
6.10 Wuhan Fine Biotech Co., Ltd.
6.10.1 Wuhan Fine Biotech Co., Ltd. Corporation Information
6.10.2 Wuhan Fine Biotech Co., Ltd. Description and Business Overview
6.10.3 Wuhan Fine Biotech Co., Ltd. CD30 (TNFRSF8) ELISA Kit Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Wuhan Fine Biotech Co., Ltd. CD30 (TNFRSF8) ELISA Kit Product Portfolio
6.10.5 Wuhan Fine Biotech Co., Ltd. Recent Developments/Updates
6.11 Abcam
6.11.1 Abcam Corporation Information
6.11.2 Abcam CD30 (TNFRSF8) ELISA Kit Description and Business Overview
6.11.3 Abcam CD30 (TNFRSF8) ELISA Kit Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Abcam CD30 (TNFRSF8) ELISA Kit Product Portfolio
6.11.5 Abcam Recent Developments/Updates
6.12 CUSABIO
6.12.1 CUSABIO Corporation Information
6.12.2 CUSABIO CD30 (TNFRSF8) ELISA Kit Description and Business Overview
6.12.3 CUSABIO CD30 (TNFRSF8) ELISA Kit Sales, Revenue and Gross Margin (2018-2024)
6.12.4 CUSABIO CD30 (TNFRSF8) ELISA Kit Product Portfolio
6.12.5 CUSABIO Recent Developments/Updates
6.13 Innovative Research
6.13.1 Innovative Research Corporation Information
6.13.2 Innovative Research CD30 (TNFRSF8) ELISA Kit Description and Business Overview
6.13.3 Innovative Research CD30 (TNFRSF8) ELISA Kit Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Innovative Research CD30 (TNFRSF8) ELISA Kit Product Portfolio
6.13.5 Innovative Research Recent Developments/Updates
6.14 Geno Technology, Inc.
6.14.1 Geno Technology, Inc. Corporation Information
6.14.2 Geno Technology, Inc. CD30 (TNFRSF8) ELISA Kit Description and Business Overview
6.14.3 Geno Technology, Inc. CD30 (TNFRSF8) ELISA Kit Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Geno Technology, Inc. CD30 (TNFRSF8) ELISA Kit Product Portfolio
6.14.5 Geno Technology, Inc. Recent Developments/Updates
6.15 Arigo Biolaboratories Corp.
6.15.1 Arigo Biolaboratories Corp. Corporation Information
6.15.2 Arigo Biolaboratories Corp. CD30 (TNFRSF8) ELISA Kit Description and Business Overview
6.15.3 Arigo Biolaboratories Corp. CD30 (TNFRSF8) ELISA Kit Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Arigo Biolaboratories Corp. CD30 (TNFRSF8) ELISA Kit Product Portfolio
6.15.5 Arigo Biolaboratories Corp. Recent Developments/Updates
6.16 LifeSpan BioSciences, Inc
6.16.1 LifeSpan BioSciences, Inc Corporation Information
6.16.2 LifeSpan BioSciences, Inc CD30 (TNFRSF8) ELISA Kit Description and Business Overview
6.16.3 LifeSpan BioSciences, Inc CD30 (TNFRSF8) ELISA Kit Sales, Revenue and Gross Margin (2018-2024)
6.16.4 LifeSpan BioSciences, Inc CD30 (TNFRSF8) ELISA Kit Product Portfolio
6.16.5 LifeSpan BioSciences, Inc Recent Developments/Updates
6.17 Biomatik
6.17.1 Biomatik Corporation Information
6.17.2 Biomatik CD30 (TNFRSF8) ELISA Kit Description and Business Overview
6.17.3 Biomatik CD30 (TNFRSF8) ELISA Kit Sales, Revenue and Gross Margin (2018-2024)
6.17.4 Biomatik CD30 (TNFRSF8) ELISA Kit Product Portfolio
6.17.5 Biomatik Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 CD30 (TNFRSF8) ELISA Kit Industry Chain Analysis
7.2 CD30 (TNFRSF8) ELISA Kit Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 CD30 (TNFRSF8) ELISA Kit Production Mode & Process
7.4 CD30 (TNFRSF8) ELISA Kit Sales and Marketing
7.4.1 CD30 (TNFRSF8) ELISA Kit Sales Channels
7.4.2 CD30 (TNFRSF8) ELISA Kit Distributors
7.5 CD30 (TNFRSF8) ELISA Kit Customers
8 CD30 (TNFRSF8) ELISA Kit Market Dynamics
8.1 CD30 (TNFRSF8) ELISA Kit Industry Trends
8.2 CD30 (TNFRSF8) ELISA Kit Market Drivers
8.3 CD30 (TNFRSF8) ELISA Kit Market Challenges
8.4 CD30 (TNFRSF8) ELISA Kit Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global CD30 (TNFRSF8) ELISA Kit Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global CD30 (TNFRSF8) ELISA Kit Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global CD30 (TNFRSF8) ELISA Kit Market Competitive Situation by Manufacturers in 2022
Table 4. Global CD30 (TNFRSF8) ELISA Kit Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global CD30 (TNFRSF8) ELISA Kit Sales Market Share by Manufacturers (2018-2024)
Table 6. Global CD30 (TNFRSF8) ELISA Kit Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global CD30 (TNFRSF8) ELISA Kit Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market CD30 (TNFRSF8) ELISA Kit Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of CD30 (TNFRSF8) ELISA Kit, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of CD30 (TNFRSF8) ELISA Kit, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of CD30 (TNFRSF8) ELISA Kit, Product Type & Application
Table 12. Global Key Manufacturers of CD30 (TNFRSF8) ELISA Kit, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global CD30 (TNFRSF8) ELISA Kit by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD30 (TNFRSF8) ELISA Kit as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global CD30 (TNFRSF8) ELISA Kit Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global CD30 (TNFRSF8) ELISA Kit Sales by Region (2018-2024) & (K Units)
Table 18. Global CD30 (TNFRSF8) ELISA Kit Sales Market Share by Region (2018-2024)
Table 19. Global CD30 (TNFRSF8) ELISA Kit Sales by Region (2024-2029) & (K Units)
Table 20. Global CD30 (TNFRSF8) ELISA Kit Sales Market Share by Region (2024-2029)
Table 21. Global CD30 (TNFRSF8) ELISA Kit Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global CD30 (TNFRSF8) ELISA Kit Revenue Market Share by Region (2018-2024)
Table 23. Global CD30 (TNFRSF8) ELISA Kit Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global CD30 (TNFRSF8) ELISA Kit Revenue Market Share by Region (2024-2029)
Table 25. North America CD30 (TNFRSF8) ELISA Kit Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America CD30 (TNFRSF8) ELISA Kit Sales by Country (2018-2024) & (K Units)
Table 27. North America CD30 (TNFRSF8) ELISA Kit Sales by Country (2024-2029) & (K Units)
Table 28. North America CD30 (TNFRSF8) ELISA Kit Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America CD30 (TNFRSF8) ELISA Kit Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe CD30 (TNFRSF8) ELISA Kit Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe CD30 (TNFRSF8) ELISA Kit Sales by Country (2018-2024) & (K Units)
Table 32. Europe CD30 (TNFRSF8) ELISA Kit Sales by Country (2024-2029) & (K Units)
Table 33. Europe CD30 (TNFRSF8) ELISA Kit Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe CD30 (TNFRSF8) ELISA Kit Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific CD30 (TNFRSF8) ELISA Kit Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific CD30 (TNFRSF8) ELISA Kit Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific CD30 (TNFRSF8) ELISA Kit Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific CD30 (TNFRSF8) ELISA Kit Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific CD30 (TNFRSF8) ELISA Kit Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America CD30 (TNFRSF8) ELISA Kit Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America CD30 (TNFRSF8) ELISA Kit Sales by Country (2018-2024) & (K Units)
Table 42. Latin America CD30 (TNFRSF8) ELISA Kit Sales by Country (2024-2029) & (K Units)
Table 43. Latin America CD30 (TNFRSF8) ELISA Kit Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America CD30 (TNFRSF8) ELISA Kit Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa CD30 (TNFRSF8) ELISA Kit Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa CD30 (TNFRSF8) ELISA Kit Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa CD30 (TNFRSF8) ELISA Kit Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa CD30 (TNFRSF8) ELISA Kit Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa CD30 (TNFRSF8) ELISA Kit Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global CD30 (TNFRSF8) ELISA Kit Sales (K Units) by Type (2018-2024)
Table 51. Global CD30 (TNFRSF8) ELISA Kit Sales (K Units) by Type (2024-2029)
Table 52. Global CD30 (TNFRSF8) ELISA Kit Sales Market Share by Type (2018-2024)
Table 53. Global CD30 (TNFRSF8) ELISA Kit Sales Market Share by Type (2024-2029)
Table 54. Global CD30 (TNFRSF8) ELISA Kit Revenue (US$ Million) by Type (2018-2024)
Table 55. Global CD30 (TNFRSF8) ELISA Kit Revenue (US$ Million) by Type (2024-2029)
Table 56. Global CD30 (TNFRSF8) ELISA Kit Revenue Market Share by Type (2018-2024)
Table 57. Global CD30 (TNFRSF8) ELISA Kit Revenue Market Share by Type (2024-2029)
Table 58. Global CD30 (TNFRSF8) ELISA Kit Price (US$/Unit) by Type (2018-2024)
Table 59. Global CD30 (TNFRSF8) ELISA Kit Price (US$/Unit) by Type (2024-2029)
Table 60. Global CD30 (TNFRSF8) ELISA Kit Sales (K Units) by Application (2018-2024)
Table 61. Global CD30 (TNFRSF8) ELISA Kit Sales (K Units) by Application (2024-2029)
Table 62. Global CD30 (TNFRSF8) ELISA Kit Sales Market Share by Application (2018-2024)
Table 63. Global CD30 (TNFRSF8) ELISA Kit Sales Market Share by Application (2024-2029)
Table 64. Global CD30 (TNFRSF8) ELISA Kit Revenue (US$ Million) by Application (2018-2024)
Table 65. Global CD30 (TNFRSF8) ELISA Kit Revenue (US$ Million) by Application (2024-2029)
Table 66. Global CD30 (TNFRSF8) ELISA Kit Revenue Market Share by Application (2018-2024)
Table 67. Global CD30 (TNFRSF8) ELISA Kit Revenue Market Share by Application (2024-2029)
Table 68. Global CD30 (TNFRSF8) ELISA Kit Price (US$/Unit) by Application (2018-2024)
Table 69. Global CD30 (TNFRSF8) ELISA Kit Price (US$/Unit) by Application (2024-2029)
Table 70. Sino Biological, Inc. Corporation Information
Table 71. Sino Biological, Inc. Description and Business Overview
Table 72. Sino Biological, Inc. CD30 (TNFRSF8) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Sino Biological, Inc. CD30 (TNFRSF8) ELISA Kit Product
Table 74. Sino Biological, Inc. Recent Developments/Updates
Table 75. Bio-Techne Corporation Information
Table 76. Bio-Techne Description and Business Overview
Table 77. Bio-Techne CD30 (TNFRSF8) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Bio-Techne CD30 (TNFRSF8) ELISA Kit Product
Table 79. Bio-Techne Recent Developments/Updates
Table 80. MyBiosource, Inc. Corporation Information
Table 81. MyBiosource, Inc. Description and Business Overview
Table 82. MyBiosource, Inc. CD30 (TNFRSF8) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. MyBiosource, Inc. CD30 (TNFRSF8) ELISA Kit Product
Table 84. MyBiosource, Inc. Recent Developments/Updates
Table 85. Boster Biological Technology Corporation Information
Table 86. Boster Biological Technology Description and Business Overview
Table 87. Boster Biological Technology CD30 (TNFRSF8) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Boster Biological Technology CD30 (TNFRSF8) ELISA Kit Product
Table 89. Boster Biological Technology Recent Developments/Updates
Table 90. Assay Genie Corporation Information
Table 91. Assay Genie Description and Business Overview
Table 92. Assay Genie CD30 (TNFRSF8) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Assay Genie CD30 (TNFRSF8) ELISA Kit Product
Table 94. Assay Genie Recent Developments/Updates
Table 95. Signalway Antibody LLC Corporation Information
Table 96. Signalway Antibody LLC Description and Business Overview
Table 97. Signalway Antibody LLC CD30 (TNFRSF8) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Signalway Antibody LLC CD30 (TNFRSF8) ELISA Kit Product
Table 99. Signalway Antibody LLC Recent Developments/Updates
Table 100. Abbexa Corporation Information
Table 101. Abbexa Description and Business Overview
Table 102. Abbexa CD30 (TNFRSF8) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. Abbexa CD30 (TNFRSF8) ELISA Kit Product
Table 104. Abbexa Recent Developments/Updates
Table 105. RayBiotech, Inc. Corporation Information
Table 106. RayBiotech, Inc. Description and Business Overview
Table 107. RayBiotech, Inc. CD30 (TNFRSF8) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. RayBiotech, Inc. CD30 (TNFRSF8) ELISA Kit Product
Table 109. RayBiotech, Inc. Recent Developments/Updates
Table 110. Thermo Fisher Scientific (China) Co., Ltd. Corporation Information
Table 111. Thermo Fisher Scientific (China) Co., Ltd. Description and Business Overview
Table 112. Thermo Fisher Scientific (China) Co., Ltd. CD30 (TNFRSF8) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Thermo Fisher Scientific (China) Co., Ltd. CD30 (TNFRSF8) ELISA Kit Product
Table 114. Thermo Fisher Scientific (China) Co., Ltd. Recent Developments/Updates
Table 115. Wuhan Fine Biotech Co., Ltd. Corporation Information
Table 116. Wuhan Fine Biotech Co., Ltd. Description and Business Overview
Table 117. Wuhan Fine Biotech Co., Ltd. CD30 (TNFRSF8) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Wuhan Fine Biotech Co., Ltd. CD30 (TNFRSF8) ELISA Kit Product
Table 119. Wuhan Fine Biotech Co., Ltd. Recent Developments/Updates
Table 120. Abcam Corporation Information
Table 121. Abcam Description and Business Overview
Table 122. Abcam CD30 (TNFRSF8) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Abcam CD30 (TNFRSF8) ELISA Kit Product
Table 124. Abcam Recent Developments/Updates
Table 125. CUSABIO Corporation Information
Table 126. CUSABIO Description and Business Overview
Table 127. CUSABIO CD30 (TNFRSF8) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. CUSABIO CD30 (TNFRSF8) ELISA Kit Product
Table 129. CUSABIO Recent Developments/Updates
Table 130. Innovative Research Corporation Information
Table 131. Innovative Research Description and Business Overview
Table 132. Innovative Research CD30 (TNFRSF8) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. Innovative Research CD30 (TNFRSF8) ELISA Kit Product
Table 134. Innovative Research Recent Developments/Updates
Table 135. Geno Technology, Inc. Corporation Information
Table 136. Geno Technology, Inc. Description and Business Overview
Table 137. Geno Technology, Inc. CD30 (TNFRSF8) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Geno Technology, Inc. CD30 (TNFRSF8) ELISA Kit Product
Table 139. Geno Technology, Inc. Recent Developments/Updates
Table 140. Arigo Biolaboratories Corp. Corporation Information
Table 141. Arigo Biolaboratories Corp. Description and Business Overview
Table 142. Arigo Biolaboratories Corp. CD30 (TNFRSF8) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. Arigo Biolaboratories Corp. CD30 (TNFRSF8) ELISA Kit Product
Table 144. Arigo Biolaboratories Corp. Recent Developments/Updates
Table 145. LifeSpan BioSciences, Inc Corporation Information
Table 146. LifeSpan BioSciences, Inc Description and Business Overview
Table 147. LifeSpan BioSciences, Inc CD30 (TNFRSF8) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 148. LifeSpan BioSciences, Inc CD30 (TNFRSF8) ELISA Kit Product
Table 149. LifeSpan BioSciences, Inc Recent Developments/Updates
Table 150. Biomatik Corporation Information
Table 151. Biomatik Description and Business Overview
Table 152. Biomatik CD30 (TNFRSF8) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 153. Biomatik CD30 (TNFRSF8) ELISA Kit Product
Table 154. Biomatik Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. CD30 (TNFRSF8) ELISA Kit Distributors List
Table 158. CD30 (TNFRSF8) ELISA Kit Customers List
Table 159. CD30 (TNFRSF8) ELISA Kit Market Trends
Table 160. CD30 (TNFRSF8) ELISA Kit Market Drivers
Table 161. CD30 (TNFRSF8) ELISA Kit Market Challenges
Table 162. CD30 (TNFRSF8) ELISA Kit Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of CD30 (TNFRSF8) ELISA Kit
Figure 2. Global CD30 (TNFRSF8) ELISA Kit Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global CD30 (TNFRSF8) ELISA Kit Market Share by Type in 2022 & 2029
Figure 4. Human Product Picture
Figure 5. Mouse Product Picture
Figure 6. Rat Product Picture
Figure 7. Porcine Product Picture
Figure 8. Others Product Picture
Figure 9. Global CD30 (TNFRSF8) ELISA Kit Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 10. Global CD30 (TNFRSF8) ELISA Kit Market Share by Application in 2022 & 2029
Figure 11. Hospital
Figure 12. Research Institute
Figure 13. Others
Figure 14. Global CD30 (TNFRSF8) ELISA Kit Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global CD30 (TNFRSF8) ELISA Kit Market Size (2018-2029) & (US$ Million)
Figure 16. Global CD30 (TNFRSF8) ELISA Kit Sales (2018-2029) & (K Units)
Figure 17. Global CD30 (TNFRSF8) ELISA Kit Average Price (US$/Unit) & (2018-2029)
Figure 18. CD30 (TNFRSF8) ELISA Kit Report Years Considered
Figure 19. CD30 (TNFRSF8) ELISA Kit Sales Share by Manufacturers in 2022
Figure 20. Global CD30 (TNFRSF8) ELISA Kit Revenue Share by Manufacturers in 2022
Figure 21. The Global 5 and 10 Largest CD30 (TNFRSF8) ELISA Kit Players: Market Share by Revenue in 2022
Figure 22. CD30 (TNFRSF8) ELISA Kit Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 23. Global CD30 (TNFRSF8) ELISA Kit Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 24. North America CD30 (TNFRSF8) ELISA Kit Sales Market Share by Country (2018-2029)
Figure 25. North America CD30 (TNFRSF8) ELISA Kit Revenue Market Share by Country (2018-2029)
Figure 26. United States CD30 (TNFRSF8) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Canada CD30 (TNFRSF8) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Europe CD30 (TNFRSF8) ELISA Kit Sales Market Share by Country (2018-2029)
Figure 29. Europe CD30 (TNFRSF8) ELISA Kit Revenue Market Share by Country (2018-2029)
Figure 30. Germany CD30 (TNFRSF8) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. France CD30 (TNFRSF8) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. U.K. CD30 (TNFRSF8) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Italy CD30 (TNFRSF8) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Russia CD30 (TNFRSF8) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Asia Pacific CD30 (TNFRSF8) ELISA Kit Sales Market Share by Region (2018-2029)
Figure 36. Asia Pacific CD30 (TNFRSF8) ELISA Kit Revenue Market Share by Region (2018-2029)
Figure 37. China CD30 (TNFRSF8) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Japan CD30 (TNFRSF8) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. South Korea CD30 (TNFRSF8) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. India CD30 (TNFRSF8) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Australia CD30 (TNFRSF8) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. China Taiwan CD30 (TNFRSF8) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Southeast Asia CD30 (TNFRSF8) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America CD30 (TNFRSF8) ELISA Kit Sales Market Share by Country (2018-2029)
Figure 45. Latin America CD30 (TNFRSF8) ELISA Kit Revenue Market Share by Country (2018-2029)
Figure 46. Mexico CD30 (TNFRSF8) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil CD30 (TNFRSF8) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina CD30 (TNFRSF8) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa CD30 (TNFRSF8) ELISA Kit Sales Market Share by Country (2018-2029)
Figure 50. Middle East & Africa CD30 (TNFRSF8) ELISA Kit Revenue Market Share by Country (2018-2029)
Figure 51. Turkey CD30 (TNFRSF8) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia CD30 (TNFRSF8) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. UAE CD30 (TNFRSF8) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Global Sales Market Share of CD30 (TNFRSF8) ELISA Kit by Type (2018-2029)
Figure 55. Global Revenue Market Share of CD30 (TNFRSF8) ELISA Kit by Type (2018-2029)
Figure 56. Global CD30 (TNFRSF8) ELISA Kit Price (US$/Unit) by Type (2018-2029)
Figure 57. Global Sales Market Share of CD30 (TNFRSF8) ELISA Kit by Application (2018-2029)
Figure 58. Global Revenue Market Share of CD30 (TNFRSF8) ELISA Kit by Application (2018-2029)
Figure 59. Global CD30 (TNFRSF8) ELISA Kit Price (US$/Unit) by Application (2018-2029)
Figure 60. CD30 (TNFRSF8) ELISA Kit Value Chain
Figure 61. CD30 (TNFRSF8) ELISA Kit Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed